Oregon § 689.662 Authority to test and prescribe, dispense and administer treatment for COVID-19; rules

Oregon Statutes

§ 689.662 — Authority to test and prescribe, dispense and administer treatment for COVID-19; rules

Oregon § 689.662

Vol.17

Title 52Occupations and Professions

Ch. 689Pharmacists; Drug Outlets; Drug Sales

This text of Oregon § 689.662 (Authority to test and prescribe, dispense and administer treatment for COVID-19; rules) is published on Counsel Stack Legal Research, covering Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Or. Rev. Stat. § 689.662 (2026).

Text

(1)Consistent with the protocols adopted by the State Board of Pharmacy by rule, as recommended by the Public Health and Pharmacy Formulary Advisory Committee, a pharmacist may test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prescribe, dispense and administer treatment, including drug therapy, for SARS-CoV-2.

(2)When testing for SARS-CoV-2, a pharmacist may use:

(a)A screening procedure that can be safely performed by a pharmacist; and

(b)A test that:

(A)Guides the pharmacist’s clinical decision-making;

(B)Is determined by the Centers for Medicare and Medicaid Services to qualify as a waived test under the Clinical Laboratory Improvement Amendments of 1988 (P.L. 100-578, 42 U.S.C. 201 and 263a) or federal regulations adopted pursuant to the Clinical Laborato

Free access — add to your briefcase to read the full text and ask questions with AI

(1) Consistent with the protocols adopted by the State Board of Pharmacy by rule, as recommended by the Public Health and Pharmacy Formulary Advisory Committee, a pharmacist may test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prescribe, dispense and administer treatment, including drug therapy, for SARS-CoV-2.
(2) When testing for SARS-CoV-2, a pharmacist may use:
(a) A screening procedure that can be safely performed by a pharmacist; and
(b) A test that:
(A) Guides the pharmacist’s clinical decision-making;
(B) Is determined by the Centers for Medicare and Medicaid Services to qualify as a waived test under the Clinical Laboratory Improvement Amendments of 1988 (P.L. 100-578, 42 U.S.C. 201 and 263a) or federal regulations adopted pursuant to the Clinical Laboratory Improvement Amendments of 1988 or is approved by the United States Food and Drug Administration; and
(C) Is approved by the board by rule for use under this section.
(3) A pharmacist may delegate to a pharmacy technician or an intern under the pharmacist’s supervision the administrative and technical tasks of performing a task described in subsection (2) of this section.
(4) The board may adopt rules as necessary to carry out this section.